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Abstract
Background: Conditioned Pain Modulation (CPM) is often used to assess human descending pain inhibition. Nine
different studies on the test-retest-reliability of different CPM paradigms have been published, but none of them
has investigated the commonly used heat-cold-pain method. The results vary widely and therefore, reliability
measures cannot be extrapolated from one CPM paradigm to another. Aim of the present study was to
analyse the test-retest-reliability of the common heat-cold-pain method and its correlation to pain thresholds.
Methods: We tested the short-term test-retest-reliability within 40 ± 19.9 h using a cold-water immersion (10 °C, left hand)
as conditioning stimulus (CS) and heat pain (43-49 °C, pain intensity 60 ± 5 on the 101-point numeric rating scale, right
forearm) as test stimulus (TS) in 25 healthy right-handed subjects (12females, 31.6 ± 14.1 years). The TS was applied 30s
before (TSbefore), during (TSduring) and after (TSafter) the 60s CS. The difference between the pain ratings for TSbefore and
TSduring represents the early CPM-effect, between TSbefore and TSafter the late CPM-effect. Quantitative sensory testing (QST,
DFNS protocol) was performed on both sessions before the CPM assessment. Statistics: paired t-tests, Intraclass correlation
coefficient (ICC), standard error of measurement (SEM), smallest real difference (SRD), Pearson’s correlation, Bland-Altman
analysis, significance level p < 0.05 with Bonferroni correction for multiple comparisons, when necessary.
Results: Pain ratings during CPM correlated significantly (ICC: 0.411…0.962) between both days, though ratings for
TSafter were lower on day 2 (p < 0.005). The early (day 1: 16.7 ± 11.7; day 2: 19.5 ± 11.9; ICC: 0.618, SRD: 20.2) and late
(day 1: 1.7 ± 9.2; day 2: 7.6 ± 11.5; ICC: 0.178, SRD: 27.0) CPM effect did not differ significantly between both days. Both
early and late CPM-effects did not correlate with the pain thresholds.
Conclusions: The short-term test-retest-reliability of the early CPM-effect using the heat-cold-pain method in healthy
subjects achieved satisfying results in terms of the ICC. The SRD of the early CPM effect showed that an individual change
of > 20 NRS can be attributed to a real change rather than chance. The late CPM-effect was weaker and not reliable.
Keywords: Conditioned pain modulation, Test-retest reliability, Quantitative sensory test, Heat-cold-pain method, Early
CPM effect, Late CPM effect
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Background
Human pain modulation is of growing interest for pain re-
search. The balance between inhibitory and facilitatory
pain systems is suggested to be disrupted in several pain
syndromes, e.g. fibromyalgia, irritable bowel syndrome or
osteoarthritis [1–3]. Furthermore, ineffective endogenous
analgesia seems to put patients at risk for developing
chronic postoperative pain [4, 5].
Experimentally, the descending inhibitory pathways
can be assessed using two noxious stimuli [6]. Plenty of
paradigms assessing the conditioned pain modulation
(CPM) have been described, using thermal, mechanical,
electrical or pressure stimuli as test stimulus (TS) and/
or conditioning stimulus (CS) in different combinations.
The so-called CPM-effect is typically calculated as the
difference between pain ratings of the TS before and the
TS during or - to analyse its persistence - after applica-
tion of the CS [7, 8]. Hitherto, there is no consensus
whether a certain CPM protocol is preferable over the
others [9].
So far, only few studies have analysed the test-retest-
reliability of different CPM paradigms for periods be-
tween 15 min and 10 months with sample sizes between
12 and 190 subjects, most of them in healthy subjects,
using different TS (heat pain, electrical stimulation, pres-
sure or ischemia) and CS (hot or cold-water baths, occlu-
sion cuff) [10–18]. However, one study focused on intra-
individual variances of the CPM-effect elicited by different
CS in 12 healthy men [17], while another focused on the
influence of ongoing pain on the CPM-effect [18], both of
them not examining genuine test-retest-reliability. Three
further studies analysed additionally gender-specific test-
retest-reliability [13, 16, 18]. To sum up, the results re-
garding the ICC vary widely between the studies and seem
to depend on the used CS and TS and the time interval
[7, 16, 17]. For most paradigms and parameters ICC
analysis revealed good to excellent test-retest reliability
in healthy subjects with some exceptions. Especially for
the CPM-effect elicited by cuff occlusion as CS and
pressure pain as TS, the ICC revealed poor reliability
(ICC −0.4) over a period of 3 days [10], whereas retest
with the same CPM paradigm within less than 60 min
showed good to excellent ICC [10, 15]. Two studies
examining the CPM-effect using electrical stimulation
as TS found good test-retest reliability over 1–4 weeks
based on both the nociceptive flexor reflex (NFR) re-
sponse and subjective pain ratings [11, 12], but it was
poor when calculated based on the electrical pain de-
tection threshold [12], though the CPM effect based on
subjective pain ratings was more reliable than based on
the NFR during innocuous stimulation as control con-
dition [11]. The authors concluded that the subjective
pain ratings and objective electrophysiological mea-
sures reflect different components of the CPM [11, 12].
In contrast, examining the CPM effect in patients with
chronic pain over an interval of about 1 week with
painful cold stimulus as CS and pressure pain as TS,
the test-retest reliability seems to be poor in males,
whereas a subanalysis in female patients showed better
test-retest reliability according to the ICC [13, 14, 18].
Therefore, extrapolation of reliability measures from
one CPM paradigm to another and between different
study populations, i.e. healthy subjects vs. patients with
chronic pain, seems to be inappropriate. Only two of
the above studies reported clinically relevant reliability
measures like standard error of measurement and
standard real difference [12, 18], though recently a re-
view on studies addressing the test-retest reliability of
sensory testing demanded for more detailed statistical
evaluations of test-retest data, including also assess-
ment of agreement of the datasets, and more transpar-
ent data presentation [19].
To prove the value of a testing paradigm for clinical
applicability, an analysis of the test-retest reliability in
healthy subjects is an essential prerequisite, as the con-
founding factors in healthy subjects are less pronounced
than in patients with an underlying disease. To our
knowledge, a detailed test-retest-reliability analysis in
healthy subjects for the commonly used method with
tonic heat as TS and tonic cold as CS [7, 20] is still lack-
ing, although this protocol seems to provide clinically
relevant information and is easily applicable, e.g. without
recording EMG activity. This paradigm was recently ap-
plied in patients with painful diabetic neuropathy and
was able to identify patients with insufficient endogen-
ous analgesia who were responders to duloxetine, which
is supposed to enhance the function of the descending
inhibitory pathways by reuptake inhibition of serotonin
and noradrenaline [21]. To evaluate the methodological
stability of this CPM paradigm for the clinical practice,
we analysed its short-term test-retest-reliability (24–72 h)
in healthy subjects (primary objective). We analysed the
difference between the pain intensity of the TS before and
(i) during the simultaneous application of the CS (“early
CPM-effect”) as well as (ii) shortly after the application of
the CS (“late CPM-effect”).
Somatosensory function can also be examined by
quantitative sensory testing (QST). The QST-protocol of
the German Research Network on Neuropathic Pain
(DFNS) is reliable and well validated [22–24]. It con-
tains, among others, the determination of thermal and
mechanical pain thresholds as well as suprathreshold
testing with mechanical pinprick stimuli for measure-
ment of the mechanical pain sensitivity (MPS) and the
wind-up ratio (WUR) [22]. Increased pain sensitivity to
pinpricks and enhanced wind-up represent two mecha-
nisms of central sensitization, implying a preponderance
of the facilitatory pathways [25, 26]. Hence, these QST
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parameters might also indirectly reflect the state of the
descending inhibitory pathways. Therefore, we also ana-




The study protocol was in accordance with the latest version
of the Declaration of Helsinki and approved by the local eth-
ics committee of the Faculty of Medicine, Ruhr-University
Bochum, Germany (Reg. Nr. 4321–12, NCT01618604).
Volunteers were recruited from June 2012 to December
2012 among students, their relatives or employees of the
University Hospital Bergmannsheil in Bochum, Germany.
Before starting the assessment, the study was described in
its entirety to the subjects, who all gave written informed
consent. All subjects received a reimbursement of 70 € for
completion of the study. Inclusion criteria were age above
18 years, right-handedness (assessed by the Edinburgh
Handedness Inventory [27]), absence of chronic pain, no
drug intake, especially no use of analgesic drugs in the last
14 days. Each subject was asked to answer a screening tool
for healthy subjects, which has previously been established
within the IMI-Europain consortium (www.imi.euro-
pa.eu). It comprises the following exclusion criteria: age
under 18 years, missing informed consent, insufficient
German language skills, current or recent pain, recent in-
take of analgesic or other drugs (except contraceptives),
consume of alcohol or energy drinks, history of neuro-
logical, dermatological, chronic internal or psychiatric dis-
eases, abnormal neurological examination, recent sleep
restriction or unusual physical exercises, and pregnancy.
Relevant depression and anxiety symptoms were addition-
ally excluded by applying the Hospital Anxiety and De-
pression Scale (HADS) prior to study begin on the first
session [28, 29]. Other study-specific exclusion criteria
were abnormal results in the baseline quantitative sensory
testing (QST) with values outside the 95 % confidence
interval for healthy subjects according to the DFNS refer-
ence database [24] in order to exclude subjects with inci-
dental or subclinical neuropathy.
One female was excluded because of an abnormal
side-to-side difference for thermal detection thresholds, in-
dicating a unilateral neuropathy. None of the subjects was
excluded due to one of the above-mentioned criteria con-
cerning the pain ratings during the CPM procedure. Thus,
a final sample size of twenty-five subjects (mean age: 31.6 ±
14.3 (21…69) years; 12 females, n = 3 > 40 years; 13 males,
n = 1 > 40 years) was used for further statistical analyses.
Study design
Subjects attended two sessions 24 to 72 h apart. Both
sessions were conducted in exactly the same way and
were performed in the afternoon (between 4 pm and
7 pm) by the same female examiner (J.G.) in the certified
QST laboratory in the University Hospital Bergmannsheil
GmbH in Bochum, Germany. On day 1, each subject an-
swered the German Version of the Pain Sensitivity Ques-
tionnaire (PSQ) [30] to assess self-reported pain sensitivity
in relation to daily life situations for correlation with the
results of the experimental setting (secondary outcome).
The test procedure is illustrated in Fig. 1. It strictly
adhered to a standardized script with standardized in-
structions, which were read out to the subjects. The
assessment began with the determination of the individual
test stimulus temperature (TSinitial), followed by QST ac-
cording to the protocol of the German Research Network
on Neuropathic Pain (DFNS) on the right and left dorsum
of the hand, lasting about 60 min. After that, we applied
the established CPM paradigm as previously described by
Granot et al. [7] with the initially defined test stimulus (TS)
and a fixed conditioning stimulus (CS) (details see below).
Adverse events were protocolled during the testing proced-
ure until 30 min after the end of the testing procedures.
The protocols for QST and CPM assessment are adapted
from Rolke et al. [22] and Granot et al. [7], respectively.
DFNS, German Research Network on Neuropathic Pain;
NRS, Numerical Rating Scale; QST, quantitative sensory
testing; CPM, conditioned pain modulation.
Conditioned pain modulation assessment
Test stimulus calibration
The TSinitial was redefined every day for each subject as
the heat stimulus temperature rated with 60 ± 5 on the
NRS (0–100) [31].
Heat stimuli were set with a thermal sensory testing de-
vice (TSA 2001-II, MEDOC, Israel, CoVAS software, ver-
sion 3.20) using a thermode with a contact area of
30x30mm and a stimulus ramp of 4 °C/s. First, subjects
rated the pain intensity on the NRS (0–100) during a
standard heat battery consisting of three stimuli (45, 46
and 47 °C) with a duration of 7 s and an inter-stimulus
interval of 35 s to determine the individual TS
temperature. The heat stimuli were applied on the right
volar forearm and the thermode was moved 30 mm prox-
imally after the first, and 30 mm distally from the middle
of the forearm after the second stimulus to prevent ther-
mal sensitization [32]. In case the standard temperatures
(45-47 °C) were rated as too painful or not painful enough,
two further stimuli of lower or higher temperature, re-
spectively, were used (43 and 44 °C or 48 and 49 °C).
Conditioning stimulus
The CS was delivered by immersion of the left hand up
to the wrist in a cold-water bath kept at 10 °C for 60s.
The temperature was measured by a calibrated quicksil-
ver thermometer (0-100 °C) with an accuracy of ±1 °C.
The CS was not individually calibrated, in accordance with
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the established protocol by Granot et al. [7] and other
studies confirming sufficient induction of a CPM-effect
with this type and intensity of the CS [10, 33].
CPM procedure
The individually determined TS temperature, correspond-
ing to a pain intensity of 60 ± 5 on the NRS (0–100) was
applied for 30 s three times during the CPM assessment
as TSbefore, TSduring and TSafter according to the protocol
by Granot et al. [7]. Each time, the subjects were asked to
rate the heat pain intensity after 10, 20, and 30 s on the
NRS (0–100) (see Fig. 1). Five minutes after the first TS
(TSbefore), subjects were asked to put their hand into the
cold water with spread fingers and without touching the
bottom or the walls of the container. Subjects rated the
cold pain intensity after 30 and 60 s (NRS, 0–100). After
30 s immersion of the hand in the cold-water bath, the TS
was applied simultaneously (TSduring) for 30 s. Subjects
rated the pain intensity again with focus on the TS after
10, 20 and 30 s. Pain ratings for the TS after 30s and the
CS after 60s were made separately at the same time, con-
centrating on the intensity of heat and cold pain,
respectively. Finally, 5 min after termination of the CS, the
TS was applied again for 30 s (TSafter) and its intensity was
rated after 10, 20 and 30 s. 30 min after the TSafter, the CS
was applied again solitarily for 60 s and its intensity was
rated after 30 and 60 s (NRS, 0–100) to analyse distraction
effects during simultaneous application of TS and CS.
Calculation of the early CPM-effect
The extent of the endogeneous analgesia was calculated as
the difference between the mean of the three pain ratings
for the TSbefore (after 10, 20 and 30s) and the mean of the
three pain ratings for the TSduring (after 10, 20 and 30s), in
accordance to previous studies [4, 7] and was defined as
early CPM-effect [4, 7].
Early CPM−effect ¼ Mean of three pain ratings TSbefore
– Mean of three pain ratings TSduring :
Calculation of the late CPM-effect
In order to evaluate the 5-min-persistence of the CPM-
effect (late CPM-effect), we furthermore calculated the
Fig. 1 Study design
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difference between the mean of the three pain ratings
for the TSbefore and the mean of the three pain ratings
for the TSafter.
Late CPM−effect ¼ Mean of three pain ratings TSbefore
– Mean of three pain ratings TSafter:
Quantitative sensory testing
In accordance to the protocol of the German Research
Network on Neuropathic Pain (DFNS), the QST assess-
ment included seven tests measuring 13 parameters [22]
and was performed on the left and right dorsum of the
hand. Before starting the QST assessment, all subjects
became familiarized with the stimuli in an area other
than the area to be tested. This standardized test battery
consisted of the cold detection threshold (CDT), warm
detection threshold (WDT), thermal sensory limen
(TSL), paradoxical heat sensations (PHS), cold pain
threshold (CPT), heat pain threshold (HPT), mechanical
detection threshold (MDT), mechanical pain threshold
(MPT), mechanical pain sensitivity (MPS), dynamic
mechanical allodynia (DMA), wind-up ratio (WUR), vi-
bration detection threshold (VDT) and pressure pain
threshold (PPT). For the warm and cold detection the
same TSA 2001-II (MEDOC, Israel, Win TSA software,
version 5.29) thermal sensory testing device was used as
for the CPM assessment (32 °C baseline temperature,
stimulus ramp of 1 °C/s, cut-off values 0 °C - 50 °C).
The mechanical detection threshold (MDT) was mea-
sured using modified von Frey filaments (Optihair2-Set,
Marstock Nervtest, Schriesheim, Germany) between
0,25 and 512mN. Modified Pin Pricks (MRC Systems,
Heidelberg, Germany) from 8 to 512mN were used for the
MPT, WUR and MPS. Light tactile stimuli (cotton wool,
brush and Q-tip) were used to assess DMA. The VDT was
determined with a Rydel-Seiffer tuning fork (64 Hz, 8/8
scale) that was placed over the ulnar styloid process. The
PPT was measured by a pressure algometer placed over
the thenar muscle (FDN200, Wagner Instruments,
Greenwich, USA, probe area: 1 cm2, stimulus ramp
0.5 kg/s, 2-20 kg/cm2).
Statistical analysis
All analyses were conducted using SPSS, Version 20
(SPSS, Chicago, IL, USA). Normal distribution of variables
was assured using the Kolmogorov-Smirnov test. Within
group differences (e.g., pain ratings day 1 vs. day 2) were
analysed using paired t-tests. For analysis of the relative
test-retest reliability between the two CPM-assessments,
i.e., the degree to which the subjects’ measurements or
scores maintained their position relative to others, we
used indices of agreement, the Pearson’s product–moment
correlation, followed by calculation of the Intraclass
Correlation Coefficient (ICC). To control for bias be-
tween measurement on both days, ICC analyses were
conducted using a two-way mixed effects model with
terms of absolute agreement. The standard error of
measurement and its 95 % confidence interval, the
smallest real difference (SRD) were calculated as abso-
lute measure for the reliability of both the early and
late CPM effect (standard error of measurement =
intra-individual standard deviation * √(1-ICC), SRD =
1.96 * standard error of measurement * √2Þ [34]. Both
parameters were calculated to reflect the sensitivity of
change of the early and late CPM effect. Measuring the
magnitude of the CPM effects, it is not only important
to calculate the ICC, but also to be able to evaluate
changes due to an intervention e.g. a pharmacological
treatment. The standard error of measurement indi-
cates the expected error between two measurements
conducted under the same circumstances in the same
subject over a defined period of time, and should not
be confused with the standard error of mean (also ab-
breviated as SEM). The lower the standard error of
measurement, the better the test-retest-reliability [34, 35].
The SRD, as the 95 % confidence interval of the SEM,
indicates the change in value that cannot be interpreted
as random scatter between two measurements in an
individual, but has to be assigned to change of circum-
stances, i.e. a treatment or intervention effect. Bland-
Altman-plots were conducted as a graphical interpret-
ation [36], displaying the relationship between the
mean CPM-effect on day 1 and day 2 on the x-axis, and
the difference between CPM effects of day 2 and day 1
for each subject on the y-axis, separately for both early
and late CPM-effect. An important part of an analysis
of reliability is the assessment not only of mean differ-
ences, but also of the variance of these differences, as
reliability is more important for single subjects than for
groups of subjects [37]. In Bland-Altman-plots, both in-
dividual effects and effects estimated on the basis of the
study group can be seen: the mean difference (i.e. bias)
between day 2 - day 1 is marked as a bold line and the
estimated 95 % limits of agreement (LoA) as thin lines,
and their 95 % confidence intervals as dashed lines.
The 95 % LoA represent the range of limits in which
95 % of the data are expected to lie, based on the study
population [37], their confidence intervals indicate the
level of uncertainty due to the variance in the dataset
and the limited number of subjects in the study popula-
tion. The lower the limits, the closer the values between
both measurements and the better the reliability.
As recommended by Biurrun Manresa et al. [12], the
clinical relevance of reliability results can become evi-
dent by calculating the estimated samples sizes. There-
fore we calculated sample sizes for the early and late
CPM effect considering crossover (i.e. intragroup
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reliability analysis, sample size = number of subjects each
receiving different assessments) and parallel (i.e. inter-
group reliability analysis, sample size = number of sub-
jects for each group) study designs, following the
guidelines described by Julious et al. [38]. The calcula-
tion is based on the question how many subjects are
needed to treat (e.g. drugs, intervention) to elevate a
former “non responder” (mean CPM effect = 0) to a
“normal responder” (in the case of the present study
population: mean early CPM effect = 18 NRS points, and
mean late CPM effect = 4 NRS points, see results). For
this purpose, we built four subgroups analysing 25, 50,
75 and finally 100 % success of treatment.
Questionnaire data from the PSQ was correlated with
the early and late CPM-effect using the Pearson correl-
ation to compare self-reported information on pain sen-
sitivity in daily-life situations and the function of the
descending pathways during the experimental setting.
Additionally, the HADS scores were correlated with the
early and late CPM-effect using the Pearson correlation
to assess any association with the magnitude of depres-
sion or anxiety scores (within the normal range).
For all analyses comprising QST data, data of the right
hand was used. QST raw data was logarithmically trans-
formed, except for PHS, CPT, HPT and PPT, as previously
described [24]. All parameters (except PHS and DMA)
were z-transformed to compare the data independently
from age, gender and region, based on the existing DFNS
reference data base [24] using the QST data analysis pro-
gram eQuiSTA (Casquar GmbH, Bochum, Germany).
Test-retest reliability analyses of the QST raw data were
performed using the ICC.
Pearson’s product moment correlation was used to as-
sess the association between the QST raw values and the
early and the late CPM-effect, respectively. Furthermore,
we conducted a median-split analysis, separating sub-
groups according to the magnitude of the early and late
CPM-effect (early CPM-effect: < 15 and ≥ 15; late CPM:
effect < 3 and ≥ 3, respectively) and comparing raw data
of each QST-parameter (after log-transformation) be-
tween these subgroups using the Mann–Whitney-U test
in order to detect discrete differences between both sub-
groups, which do not appear in the correlation analysis
considering the whole group.
A p-value of 0.05 was considered to be statistically sig-
nificant, and Bonferroni corrections for multiple com-
parisons were applied for each test group.
Results
Subjects’ characteristics and baseline measures
Measurements were repeated within 40 ± 19.9 h. In all
subjects a TSinitial with a pain rating of 60 ± 5 on the
NRS (0–100) could be determined at both days with a
temperature between 45 and 49 °C. 6 subjects had a
difference of 1 °C in their TSinitial between both days. All
subjects could tolerate the 10 °C cold-water bath for 60s.
Mild erythema was detected in all subjects in the appli-
cation area of the thermode, disappearing within 30 min
after testing. Two subjects complained about pain up to
the shoulder and one about nausea during the cold-
water immersion.
CPM magnitude on day 1 and day 2
On each day, all but one subject (96 %) had an early
CPM-effect >0, indicating that the endogenous pain in-
hibition during simultaneous cold-water immersion was
induced in nearly all subjects. The subject without posi-
tive early CPM-effect on both days was not the same.
Regarding the whole study group on both days, the pain
rating for the TS before application of the CS (TSbefore)
significantly decreased during the simultaneous CS ap-
plication (TSduring, p < 0.01), indicating also a statistically
relevant early CPM-effect (see Fig. 2a). The size of the
early CPM-effect was 28 on day 1 and 33 % on day 2.
In contrast, a late CPM-effect > 0 was seen only in 14
subjects on day 1 (56 %) and 16 subjects on day 2
(64 %), indicating that endogenous pain inhibition lasted
longer than 5 min after termination of the CS only in
part of the subjects. 9 subjects (36 %) showed a late
CPM-effect on both days, 4 subjects (16 %) presented no
late CPM-effect on both days. The group analysis re-
vealed a significant decrease of the pain ratings after CS
application (TSbefore vs. TSafter) only on day 2 (p < 0.01,
day 1: p = 0.376; see Fig. 2b). The size of the late CPM-
effect was 3 on day 1 and 15 % on day 2.
Significant correlations between the magnitude of the
pain ratings for the cold water immersion (CS) and the
resulting CPM effect could not be observed.
Test-retest-reliability of conditioned pain modulation
After Bonferroni correction for multiple testing there
were no significant differences between both days re-
garding the reported pain intensities (NRS, 0–100) for
TSinitial, TSbefore, TSduring, CS30s and CS60s, the early
CPM-effect or the late CPM-effect (Table 2). Only the
pain ratings for TSafter were significantly lower on day 2.
Each of the individual parameters of the CPM protocol
demonstrated a significant close to moderate correlation
between both days based on the ICC (Table 1). Concern-
ing the composite parameters, the correlation of the
early CPM-effect between both days was good; however,
there was no significant correlation of the late CPM-
effect between both days.
For the early CPM-effect the standard error of meas-
urement (SEM) was 7.3 on the 0–100 NRS scale, repre-
senting 40 % of the mean CPM-effect (Table 2). For the
late CPM-effect, the SEM was 211 % as big as the mean
(Table 2). The smallest real difference (SRD) indicated that
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a change larger than 20.2 NRS points for the early
CPM effect, and 27.0 NRS points for the late CPM
effect in an individual case has to be assigned to a
real change and not random scatter between measure-
ments (Table 2).
Given the fact, that a CPM “non-responder” might
have a CPM effect of 0, and a “normal responder”
might have a mean CPM effect with 18 NRS points
for the early CPM effect, and 4 NRS points for the
late CPM effect (Table 2), we calculated hypothetical
sample sizes for crossover and parallel designs in
terms of successful treatment (Table 3). In case of
50 % treatment success after an intervention, 18 sub-
jects are needed to confirm this hypothesis in the
crossover design, and 68 subjects in the parallel de-
sign for the early CPM effect. For the late CPM effect
Fig. 2 Graphic illustration of the CPM effect’s calculation. a Whisker plots of the mean of three pain ratings for TSbefore and TSduring, resulting in
the early CPM-effect. b Whisker plots of the mean of three pain ratings for TSbefore and TSafter, resulting in the late CPM-effect. The bottom and the top
of the boxes represent the first and third quartiles, the band inside is the median. The ends of the whiskers illustrate the maximum and minimum. TS
were applied before, during and after the conditioning stimulus. CPM, conditioned pain modulation; NRS, numeric rating scale; TS, test stimulus
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the number of subjects needed to confirm such a hy-
pothesis is beyond the clinical relevance.
The Bland-Altman Plot for the early CPM effect
(Fig. 3a) showed a range for the 95 limits of agreement
(LoA) between −17.4 (95 CI: −21.5…-13.4) NRS points
(0–100) and 23.0 (95 % CI: 19.0…27.1) NRS points. The
late CPM effect (Fig. 3b) showed a range for the 95 LoA
between −20.2 (95 CI: −25.4… -15.0) NRS points and
32.1 (95 % CI: 26.9… 37.3) NRS points (Table 2). Re-
garding the absolute range, the limits for the late CPM
effect were approximately 30 % wider than for the early
CPM effect. Figure 3a shows all values evenly distributed
around the mean difference (bold line = bias), 11/25
subjects are below the mean difference, 14/25 subjects
above, indicating no systematic deviation between the
measurements, that could be assigned, for example,
to learning effects (correlation r = 0.019, p = 0.928).
The mean early CPM effect between both days ranges
between 0–50 NRS points, the mean difference be-
tween −17 and + 18 NRS points. The range for the mean
late CPM effect between both days is between −8 and 25
NRS points, the mean difference between −19 and +33
NRS points.
The early and late CPM-effect did not correlate signifi-
cantly neither on day 1 (r = 0.330, p = 0.107) nor on day
2 (r = 0.375, p = 0.065).
Quantitative sensory testing
Test-retest reliability of quantitative sensory testing
After z-transformation, all subjects showed QST param-
eters within the normal range between −1.96 and 1.96,
as expected. One male subject (63 years) reported 1 (of 3)
paradoxical heat sensations on day 1. None of the subjects
had dynamic mechanical allodynia.
In the whole study group, all QST parameters corre-
lated significantly between day 1 and day 2 (ICC =
0.450…0.916) except for the cold detection threshold
(CDT, ICC = 0.265).
Correlation of quantitative sensory testing and CPM-effects
There were no significant correlations between the mag-
nitude of the early and late CPM-effect and all QST pa-
rameters, which were present at both days. After
Bonferroni correction, the correlation between the heat
pain threshold (HPT) and the late CPM-effect on day 2
was not significant (r = − 0.401, p = 0.047, Table 4).
Table 1 Parameters of the Conditioned Pain Modulation (CPM) assessment
t-test (p)a Intraclass correlation coefficientb
day 1 day 2 day 1 vs. day 2
TS temperature rated with NRS 60 (°C) total 47.5 ± 1.1 (45…49) 47.5 ± 1.0 (46…49) 0.999 0.881 (p < 0.001)**
Pain rating of TSinitial total 64.6 ± 6.8 (55…80) 64.6 ± 8.4 (45…80) 0.974 0.679 (p < 0.001)
**
Mean of three pain rating of TSbefore total 60.5 ± 7.9 (50…82) 58.4 ± 5.8 (50…70) 0.376 0.411 (p < 0.05)
Pain rating of CS30s total 57.7 ± 17.9 (20…90) 56.7 ± 19.3 (20…88) 0.698 0.765 (p < 0.001)
**
Mean of three pain rating of TSduring total 43.7 ± 10.0 (26…62) 38.9 ± 14.3 (10…65) 0.018 0.702 (p < 0.001)
**
Pain rating of CS60s total 66.3 ± 20.1 (30…90) 67.5 ± 21.7 (30…95) 0.515 0.906 (p < 0.001)
**
Mean of three pain rating of TSafter total 58.8 ± 11.7 (40…82) 50.8 ± 11.7 (23…70) 0.003* 0.480 (p < 0.01)
Pain rating of CS30s after total 57.9 ± 18.5 (15…85) 55.6 ± 19.3 (20…95) 0.282 0.843 (p < 0.001)
**
Pain rating of CS60s after total 70.8 ± 19.2 (18…90) 69.5 ± 20.3 (20…95) 0.355 0.946 (p < 0.001)
**
Early CPM effect total 16.7 ± 11.7 (−5…44) 19.5 ± 11.9 (−3…52) 0.187 0.618 (p < 0.001)**
Late CPM effect total 1.7 ± 9.2 (−25…18) 7.6 ± 11.5 (−5…37) 0.035 0.178 (p = 0.192)
All values are presented as mean ± SD and range. All data represent pain ratings on the numeric rating scale (NRS, 0–100), unless otherwise indicated. CS
conditioning stimulus, TS test stimulus; CPM conditioned pain modulation. The early CPM effect is calculated as the difference between mean pain ratings of
TSbefore and TSduring. The late CPM effect is calculated as the difference between the mean pain ratings of TSbefore and TSafter
apaired t-test CPM-effect day 1 vs. day 2
bIntraclass Correlation Coefficient (ICC) between CPM parameters day 1 and day 2
*p < 0.005 (after Bonferroni correction)
**p < 0.005 (after Bonferroni correction)
Table 2 Test-retest-reliability analyses for the mean early and late CPM effect (day 1 vs. day 2), n = 25
Mean SD Bland-Altman analysis bias (lower LoA-upper LoA) ICC (95 % CI) SEM SRD
early CPM effect 18.1 11.8 2.8 (−17.4… 23.0) 0.618 (0.302-0.811) 7.3 20.2
late CPM effect 4.6 10.7 6.0 (−20.2… 32.1) 0.178 (−0.226-0.530) 9.7 27.0
CPM Conditioned Pain Modulation, mean values for the CPM effect day 1 and day 2 represent pain ratings on the numeric rating scale (NRS, 0–100). SD; standard
deviation, ICC Intraclass Correlation coefficient, CI confidence interval, LoA limits of agreement, SEM standard error of measurement, SRD smallest real difference.
The standard error of measurements has the same units as the CPM measurements (NRS, 0–100) and is calculated as SEM = SD * √1-ICC. The SRD represents the
95 % confidence interval of the SEM, i.e., SRD = 1.96 * SEM * √2. For this table we assembled the mean values for the early and late CPM effect on both test days
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Likewise, median split analyses regarding the early and
late CPM-effect revealed no significant differences be-
tween all QST parameters, which occurred on both days,
especially regarding the thermal (CPT: p = 0.609…0.936,
HPT: p = 0.344…0.936) and mechanical pain thresholds
(MPT: p = 0.244…0.979, PPT: p = 0.205…0.467) and
parameters of the stimulus–response-function (MPS:
p = 0.046…0.809, WUR, p = 0.470…0.979).
Questionnaires
The scores for the HADS were within the range for
healthy subjects (subscore for anxiety: 3.0 ± 2.2 (0…5);
subscore for depression: 1.4 ± 1.7 (0…5)). The mean PSQ
Table 3 Hypothetical sample size calculations for crossover and
parallel designs in terms of successful treatment
Patients return to
normal CPM effect
(rate of treatment success)
Early CPM effect Late CPM effect
Crossover Parallel Crossover Parallel
100 % 6 18 45 176
75 % 10 34 122 484
50 % 18 68 272 542
25 % 84 330 1084 4332
CPM Conditioned Pain Modulation. Calculations are based on the question
how many subjects are needed to treat to elevate “non responders” to
“normal responders” in case of 25/ 50/ 75/ 100 % treatment success. All values
are given as the number of subjects for each group
Fig. 3 Bland-Altman plot for the CPM-effect on day 1 and the difference between the CPM-effect on day 2 and day 1. a early CPM-effect (r =0.019,
p = 0.928), b late CPM-effect (r = 0.215, p = 0.302). The bold line is the mean difference of the CPM-effect of both days, the dashed lines represent the
95 % limits of agreement. CPM, Conditioned Pain Modulation; NRS, numeric rating scale
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scores (3.4 ± 1.4 (0.6…6.1) were similar to the data for
healthy subjects originally reported by the authors
(3.6 ± 1.2 [30]).
Regarding the whole study group, no significant corre-
lations were found between PSQ, HADS overall score
and subscores for anxiety and depression and the early
or late CPM-effect.
Discussion
To summarize, we induced endogenous pain inhib-
ition with CPM-effect >0 using cold-water immersion
as CS in almost all healthy subjects on both days.
However, in >1/3 of them it lasted for less than
5 min after the CS termination. The absolute magni-
tude of the early CPM-effect (during simultaneous CS
application) was similar on both days and was con-
sistent with most of the previous studies [20], though
in contrast to some others, which reported lower [39, 40]
or higher CPM-effects [17, 41, 42]. For the early
CPM-effect, the test-retest-reliability within the period
of 24-72 h assessed in healthy subjects showed a
SEM of about 40 % of the mean and a SRD of 20
(on the NRS 0–100). In contrast, the reliability of the
late CPM-effect, assessed 5 min after CS termination,
was rather insufficient, represented in a SRD nearly
six times bigger than the mean effect, making the de-
tection of a real change between two assessments
within a subject nearly impossible and estimated sam-
ple sizes for experimental studies rather unrealistic.
Neither thermal nor mechanical pain thresholds, nor
QST parameters comprising suprathreshold stimuli
correlated with either CPM-effect.
Differences between the CPM paradigms regarding the
test-re-test-reliability
So far, nine studies have been published analysing the
test-retest reliability of different CPM paradigms, than
the one we used [10–18]. Three of them analysed the re-
liability in chronic pain patients or in an experimental
pain model for acute musculoskeletal pain [13, 14, 18].
The remaining six studies analysed the test-retest-
reliability in healthy subjects using the nociceptive with-
drawal reflex (NWR), electric, pressure or heat pain as
TS and cold- or hot-water baths and ischemia as CS.
Three studies reported similar ICC as in our study ran-
ging between 0.54 and 0.69 [10, 11, 15]. However, two
studies reported insufficient reliability based on ICC:
Biurrun et al. used NWR thresholds, electrical pain
thresholds and suprathreshold electrical pain as TS and
cold-water bath as CS with ICC of 0.09 to 0.44 within
1–3 weeks for suprathreshold electrical pain [12]. An-
other study in healthy females used heat both as TS and
CS and achieved ICC = 0.39 for retests over a period of
7–10 months [16]. In contrast, our study concentrated
on the short-term test-retest-reliability, which might
explain the better ICC, pointing to a more stable
CPM-effect over shorter periods of time. Choosing an ap-
propriate time period for reassessment is an important as-
pect. While re-assessment over very short time periods of
60 min or less [Cathcard2009; Lewis2012] might be more
reliable, very short time periods might be insufficient to
expect a real treatment effect when examining e.g.
changes in the CPM-effect due to an intervention. On the
other hand longer time periods between reassessments
implicate changed external conditions which might influ-
ence the results, especially when examining patients, also
Table 4 Correlational analyses between CPM effects and QST parameters at day 1 and day 2
Pearson’s correlation coefficient
QST vs. early CPM effect day 1 QST vs. early CPM effect day 2 QST vs. late CPM effect day 1 QST vs. late CPM effect day 2
CDT (log) total 0.008 (p = 0.969) −0.080 (p = 0.704) −0.143 (p = 0.497) 0.311 (p = 0.131)
WDT (log) total −0.175 (p = 0.402) −0.017 (p = 0.935) −0.125 (p = 0.553) −0.133 (p = 0.528)
TSL (log) total −0.136 (p = 0.517) −0.096 (p = 0.648) 0.108 (p = 0.608) 0.088 (p = 0.675)
CPT (°C) total 0.059 (p = 0.778) 0.158 (p = 0.449) 0.055 (p = 0.795) 0.349 (p = 0.088)
HPT (°C) total −0.103 (p = 0.624) −0.087 (p = 0.679) 0.065 (p = 0.757) −0.401 (p = 0.047)
MDT (log) total −0.103 (p = 0.624) 0.042 (p = 0.840) 0.057 (p = 0.787) 0.122 (p = 0.561)
MPT (log) total 0.210 (p = 0.314) −0.020 (p = 0.923) 0.203 (p = 0.330) −0.213 (p = 0.308)
MPS (log) total 0.049 (p = 0.815) −0.202 (p = 0.333) −0.142 (p = 0.500) 0.020 (p = 0.926)
WUR (log) total −0.118 (p = 0.574) −0.200 (p = 0.338) −0.042 (p = 0.843) 0.211 (p = 0.312)
VDT (n/8) total 0.317 (p = 0.122) 0.336 (p = 0.100) 0.217 (p = 0.297) −0.129 (p = 0.538)
PPT (log) total −0.085 (p = 0.687) −0.011 (p = 0.959) 0.184 (p = 0.380) −0.337 (p = 0.100)
Correlational analyses between each QST parameter (logarithmically transformed, except for CPT HPT, VDT) and the CPM effect’s magnitude were conducted using
Pearson’s Correlation Coefficient for measurements at day 1 and day 2. CDT Cold Detection Threshold, CPT Cold Pain Threshold, HPT Heat Pain Threshold, MDT
Mechanical Detection Threshold, MPS Mechanical Pain Sensitivity; MPT Mechanical Pain Threshold, PPT Pressure Pain Threshold, QST Quantitative Sensory Testing,
TSL Thermal Sensory Limen; VDT Vibration Detection Threshold, WDT Warm Detection Threshold, WUR Wind up Ratio
Level of significance after Bonferroni correction: p<0.001
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in relatively short term of about 1 week [13, 14] which is
pronounced in male patients [13]. There is also some evi-
dence, that different CPM paradigms engage different
spinal or supraspinal inhibitory mechanisms [43–45]; e.g.,
the magnitude and stability of CPM-effects with the use of
subjectively reported pain intensities was shown to be
stronger than objective measures like the NWR [44, 45].
Furthermore, most studies reported only ICC values as
measure for test-retest-reliability [10, 11, 13–16]. One
study showed higher ICC values for the CPM-effect
based on subjective pain ratings compared to electro-
physiological responses during the NWR (ICC 0.44 vs
0.26, [12]), while another reported similar ICC values
over 28 days for both TS (ICC 0.54 vs 0.61, [11]). It has
been previously discussed that cognitive influences may
represent a stable confounder between test and retest
session, thus explaining the slightly better reliability in
our study in comparison to a study examining the CPM
elicited by the same CS based on electrophysiological
measures [12]. Only a few studies conveyed ICC analysis
also of the single parameters during CPM assessment,
i.e. of CS as well as TS before, during and after CS appli-
cation). In terms of the ICC, the pain rating of the CS in
our study indicated excellent reliability with higher
values (ICC 0.77-0.95) than previously reported when
using the same CS in patients with chronic pain (ICC
0.61-0.67) [13] and similar ICC as when heat was used
as CS (ICC 0.79) [16]. Though tonic heat has been previ-
ously suggested to be more constant and less con-
founded by changes in cardiovascular activity in healthy
subjects compared with cold water stimuli [11, 46], our
results suggest that both conditioning stimuli are at least
comparable regarding their retest-reliability. The current
evidence suggests that both tonic cold and heat stimuli
as CS seem to be superior to cuff occlusion as CS, as the
latter was able to induce a reliable CPM effect only up
to 60 min, but not over a period of 3 days, [10, 15].
Only two reported SEM and SRD values [12, 18],
which allow much more realistic estimation of the clin-
ical relevance in terms of evaluating the outcome after
intervention based on the CPM-effect. While Biurrun et
al. [12] studied a completely different CPM-paradigm
with electrical stimulation as TS, Valencia et al. assessed
similar protocol as ours with repeatedly applied heat
pulses as TS and cold pain as CS and reported a minimal
detectable change of about 17 in the healthy cohort for
re-test measurement within two minutes independently
on the fact whether additionally the healthy subjects ex-
perienced exercise induced muscle pain or not [18].
For the first time, we report a smallest real difference
for the commonly used protocol within a re-test period
of 24-72 h, an interval which might be more relevant in
term of evaluation a therapeutic interventions based on
the CPM-effect. Our results depict that, using the
presented CPM-protocol with respect to the early CPM-
effect, a smallest real difference more than 20 points on
the 0–100 NRS between two measurements in a healthy
individual is relevant and can be assigned to change of
circumstances, and is not a random scatter. In accord-
ance to our findings, in a subgroup of patients with
polyneuropathy, who did not have any pain relief after
duloxetin treatment, presented with a more efficient
CPM already prior to treatment and the CPM-effect
changed on average about 10 on a 101-point NRS after
treatment [21]. In contrast, in the subgroup of patients
with sufficient pain relief after treatment with duloxetin,
the change in CPM-effect was on average 15. This repre-
sents a value below the calculated SRD in our study and
indicates that in pathological states with impaired CPM
even smaller changes than in healthy states, might be
clinical relevant. On the other hand, it implicates that
further studies examining the test-retest-reliability in pa-
tients with chronic pain and CPM impairment without
intervention between the measurements are needed to
strengthen this hypothesis.
Only one study evaluated the reliability of a CPM
paradigm by calculating sample sizes for potential exper-
iments, thus using a clinically more relevant parameter
than the pure calculation of the ICC [12]. Under the ex-
perimental conditions described here, the sample sizes
and consequently the reliability of the early CPM-effect
are certainly acceptable and realistic for experimental or
clinical use, especially for a crossover design (Table 3).
For example, in case of an intervention, which is
intended to normalize the CPM-effect in 50 % of the
treated patients, who were previously incapable to acti-
vate their CPM, one would need a study sample of at
least 18 subjects for crossover and 68 subjects for paral-
lel design to detect a significant change after the inter-
vention. Such estimations for calculating hypothetical
sample sizes should be demanded also for other studies
on re-test-reliability, as they provide a much more realis-
tic measure for the clinical relevance of the data than
statistical measures like the ICC.
Persistence of the CPM effect after termination of the
conditioning stimulus
In our study, the late CPM-effect, i.e. endogenous inhib-
ition lasting for at least 5 min after CS termination, was
smaller than the early CPM-effect, in line with previous
studies [8, 41, 47, 48]. It also varied largely between both
days, though statistically not significant after Bonferroni
correction, resulting in its insufficient test-retest-
reliability and unacceptably high sample sizes in com-
parison to those for the early CPM-effect to detect the
same effect. Even though there were no correlations be-
tween the magnitude of the CS rating and the resulting
CPM-effect, one might argue that the early CPM-effect
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is simply the result of distraction by the painful cold-water
bath. Though, combined distraction and CPM induced
greater pain reduction than either alone [49]. Moreover,
different extents of cortical activation in frontal and som-
atosensory areas were found by distraction and by CPM
[50]. Our findings point to an influence of distraction on
CPM, but nevertheless support the existence of a “real”
CPM-effect, which however seems to have a higher inter-
individual variability. One study reported no late CPM-
effect at all [51], whereas another found greater and longer
lasting effects of pain inhibition [52], both assessing the
CPM-effect as change in the TS intensity (pain threshold)
and not of the pain intensity as in our protocol. These in-
consistent findings indicate that the duration of the CPM-
effect after CS termination might differ depending on the
applied stimuli, but also depending on the chosen read-
out, i.e. change in pain intensity of a predefined stimulus
or change of pain threshold.
Correlations between CPM and detection/ pain thresholds
as well as suprathreshold stimulation
Another objective of the present study was to assess pos-
sible correlations between the CPM-effects and parameters
of a standardized QST-protocol. Theoretically, subjects can
be positioned in a continuum between pro- and anti-
nociception, e.g., a “pro-nociceptive subject” would have a
low CPM-effect and show low pain thresholds and high
pain ratings for suprathreshold stimuli in his sensory pro-
file [9]. Surprisingly, we found no correlations between
QST parameters and the early or late CPM-effect. Previous
studies on CPM using pain thresholds as TS showed suffi-
cient CPM-effects resulting in pain threshold increase
[2, 53, 54]. However, whilst others analysed pain thresh-
olds as TS, i.e. read-out for the CPM-effect, we analysed
for the first time correlations between the sensory profile
and the CPM-magnitude. Despite applying the same stim-
uli, our CPM paradigm uses suprathreshold stimuli,
whereas during the QST according to the DFNS-protocol
mainly subthreshold stimuli are applied, i.e. until the first
perception of pain. These thermal and mechanical pain
thresholds did not correlate with the early and late CPM-
effect. Suprathreshold stimulation within the DFNS-
protocol is only conducted using pinpricks assessing the
mechanical pain sensitivity and the wind-up ratio, but they
were also not associated with the CPM-effects, probably
pointing to different neuronal pathways [21, 22, 43, 55].
Given the high reliability of the QST parameters of the
DFNS-protocol [23], replicated in this study, the rather
large variability of the CPM magnitude seems not to influ-
ence the parameters of the sensory profile.
Influencing factors on the magnitude of the CPM-effect
Depression and anxiety have been shown to partly influ-
ence pain thresholds and suprathreshold testing [55–59]
and are linked to neurotransmitters deficiency including
serotonin and dopamine, which are also involved in the de-
scending nociceptive inhibitory pathways [60–62]. As ex-
pected, in our sample of heathy subjects all HADS scores
were within the normal range [29, 63]. Thus, analysing the
relationship between these psychiatric symptoms and CPM
was not diagnostically conclusive, though there was no cor-
relation with the early or the late CPM-effect. Also the
PSQ exploring the perception of potential daily life pain
[30] did not correlate with CPM-effects. This was some-
how unexpected, as the PSQ score was reported to correl-
ate significantly with experimental pain ratings in healthy
subjects having similar PSQ scores as our study population
[30]. However, because PSQ-score correlates with QST pa-
rameters [30] and QST does not correlate with CPM-
effects in the present study our results are not unexpected.
For pain patients any associations to both psychometric
scales should be further explored.
Limitations
In our study, we used an established protocol [7], where-
upon the TS calibration was conducted with a 7 s tonic
heat stimulus, while the TS during the CPM procedure
lasted 30 s. Time is a critical parameter with regard to
pain intensity, as either habituation or sensitisation can
occur during application of long-lasting stimuli. In fu-
ture studies, the same length of TS application for the
calibration and during CPM-testing should be consid-
ered. Another point was that the CS was not individually
calibrated. Though the used cold-water immersion was
reported to be a sufficient CS [7, 17], the high variability
of the perceived cold pain intensity might account for
the lack of individualized CS calibration. As a psycho-
physical method, CPM is susceptible to emotional and
cognitive factors, such as expectation [64, 65], stress [40]
or distraction [40, 49], which might play a role in our
study as subjects were not initially familiarized with the
CPM procedure. This might explain the higher CPM-
effects on day 2, when they were more accustomed to
the situation. For future studies, familiarization with the
experimental set-up should be obligate. Also experienced
and non-experienced subjects should not be included
into one study, and information about the familiarization
procedures should be reported in detail.
The lack of control task is another limitation of the
study, because a pain habituation after repeated applica-
tion of the TS, accounting partly for the observed pain
reduction, cannot be excluded, as thermal heat pain ap-
plied by a thermode significantly habituated within the
first 6 stimuli [66]. Generally, one main critic against the
concept of conditioned pain modulation is the fact that
the CPM-effects might be just the result of peripheral
habituation or distraction (see above). However, it could
be demonstrated that the CPM-experimental paradigm
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produced significantly more pain reduction than the ha-
bituation paradigm and the paradigm involving non-
noxious inhibitory control [67]. Granot et al. [7] using
the very same CPM protocol as we did, have also found
that only immersion of the dominant hand in 12 °C cold
and 46.5 °C hot water, but not in the conditions with less
painful cold or warm water, elicited a significant CPM-
effect comparable to that in our study.
Due to organisational reasons the time interval be-
tween both CPM-assessments ranged between 1–3 days.
Thus, possible learning effects might have influenced the
results of subjects with 24-h-intervals in-between CPM-
assessments differently than those with longer breaks.
Our aim was not to analyse gender differences, which
explains the comparatively small chosen sample size.
The sample variability within the group with subjects be-
tween 21 and 69 years, might have been quite high, as it
is well known that age and sex can affect attentional
processes. Though, to minimize such effects, we comple-
mented our analyses for the standard error of measure-
ment to compare not only interindividual, but also
intraindividual differences. Furthermore we did not spe-
cify the menstrual cycle phase in all female subjects. On
this issue, there exist divergent opinions: Rezaii et al.
showed that female sex hormones modulate CPM [68],
while Wilson et al. demonstrated no variations between
CPM during the menstrual cycle [16]. Further reliability
studies using the heat-cold-pain method for CPM are
needed with a larger sample size to analyse gender and
differences regarding the retest-reliability and differences
during the menstrual cycle, as appropriate. Additionally,
the retest-reliability for longer time-intervals such as
weeks or months should be also further examined, which
are more relevant for follow-ups in chronic pain patients.
For principle reasons, the validity of this method in pa-
tients cannot be evaluated in healthy subjects. Accord-
ingly, also the clinical relevance of the early and especially
of the late CPM-effect needs further exploration.
Conclusions
In conclusion, we evaluated the most commonly used
method for CPM with heat and cold pain as TS and CS,
respectively, demonstrating a sufficient reliability for the
early CPM-effect and associated parameters within 48 h,
but not for the late CPM-effect. Based on the SRD and
SEM as well as considering the above-mentioned limita-
tions, sample size calculations for studies using CPM-
effect, evaluated during simultaneous application of
tonic heat as TS and tonic pain as CS, as a primary
outcome are realistic for experimental or clinical use.
Based on our hypothetical sample size calculations
crossover design should be preferred rather than par-
alleled design, due to the high interindividual variabil-
ity of endogenous analgesia.
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